Bortezomib Market
Bortezomib Market - Global Industry Assessment & Forecast
#
Pages:
220
Base Year:
2024
Jan - 2025
Format:
Report Code:
VMR-4046
Segments Covered
By
Types 1mg, 3.5mg, 5mg, Others
-
By
Applications Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Others
-
By
Route of Administration Oral, Intravenous, Subcutaneous, Others
-
By
Dosage Tablet, Injection, Powder, Others
-
By
Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
-
By
End-Users Clinic, Hospital, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2024 |
| Forecast
Years:
|
2025 - 2035 |
 Historical
Years:
|
2019 - 2023 |
 Revenue
2024: |
USD 25.1 Million |
 Revenue 2035:
|
USD 41.16 Million |
 Revenue CAGR
(2025 - 2035): |
4.6% |
Fastest Growing Region (2025 -
2035)
|
Asia Pacific |
Largest Region (2024):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Bortezomib Market Segment Analysis
- Bortezomib Types Outlook (Revenue, USD Million, 2018 - 2030)
- 1mg
- 3.5mg
- 5mg
- Others
- Bortezomib Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Bortezomib Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Intravenous
- Subcutaneous
- Others
- Bortezomib Dosage Outlook (Revenue, USD Million, 2018 - 2030)
- Tablet
- Injection
- Powder
- Others
- Bortezomib Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Bortezomib End-Users Outlook (Revenue, USD Million, 2018 - 2030)
- Clinic
- Hospital
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
-
North America Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
-
North America Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
-
North America Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
-
North America Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
North America Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- U.S.
- U.S. Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- U.S. Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- U.S. Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- U.S. Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- U.S. Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- U.S. Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- U.S. Bortezomib Market, by Types
- Canada
- Canada Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Canada Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Canada Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Canada Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Canada Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Canada Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Canada Bortezomib Market, by Types
-
Mexico
- Mexico Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Mexico Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Mexico Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Mexico Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Mexico Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Mexico Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Mexico Bortezomib Market, by Types
-
North America Bortezomib Market, by Types
- Europe
-
Europe Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
-
Europe Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
-
Europe Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
-
Europe Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
-
Europe Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Europe Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- U. K.
- U.K. Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- U.K. Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- U.K. Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- U.K. Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- U.K. Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- U.K. Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- U.K. Bortezomib Market, by Types
- France
- France Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- France Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- France Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- France Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- France Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- France Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- France Bortezomib Market, by Types
-
Germany
- Germany Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Germany Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Germany Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Germany Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Germany Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Germany Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Germany Bortezomib Market, by Types
-
Italy
- Italy Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Italy Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Italy Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Italy Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Italy Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Italy Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Italy Bortezomib Market, by Types
-
Spain
- Spain Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Spain Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Spain Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Spain Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Spain Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Spain Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Spain Bortezomib Market, by Types
-
Rest of Europe
- Rest of Europe Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Rest of Europe Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Rest of Europe Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Rest of Europe Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Rest of Europe Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Europe Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Rest of Europe Bortezomib Market, by Types
-
Europe Bortezomib Market, by Types
- Asia Pacific
-
Asia Pacific Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
-
Asia Pacific Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
-
Asia Pacific Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
-
Asia Pacific Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
-
Asia Pacific Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Asia Pacific Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- China
- China Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- China Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- China Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- China Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- China Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- China Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- China Bortezomib Market, by Types
- Japan
- Japan Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Japan Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Japan Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Japan Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Japan Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Japan Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Japan Bortezomib Market, by Types
-
Germany
- Germany Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Germany Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Germany Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Germany Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Germany Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Germany Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Germany Bortezomib Market, by Types
-
India
- India Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- India Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- India Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- India Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- India Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- India Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- India Bortezomib Market, by Types
-
South Korea
- South Korea Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- South Korea Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- South Korea Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- South Korea Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- South Korea Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South Korea Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- South Korea Bortezomib Market, by Types
-
South East Asia
- South East Asia Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- South East Asia Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- South East Asia Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- South East Asia Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- South East Asia Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South East Asia Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- South East Asia Bortezomib Market, by Types
-
Rest of Asia Pacific
- Rest of Asia Pacific Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Rest of Asia Pacific Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Rest of Asia Pacific Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Rest of Asia Pacific Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Rest of Asia Pacific Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Asia Pacific Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Rest of Asia Pacific Bortezomib Market, by Types
-
Asia Pacific Bortezomib Market, by Types
- Latin America
-
Latin America Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
-
Latin America Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
-
Latin America Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
-
Latin America Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
-
Latin America Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Latin America Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Brazil
- Brazil Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Brazil Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Brazil Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Brazil Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Brazil Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Brazil Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Brazil Bortezomib Market, by Types
- Argentina
- Argentina Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Argentina Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Argentina Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Argentina Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Argentina Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Argentina Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Argentina Bortezomib Market, by Types
-
Rest of Latin America
- Rest of Latin America Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Rest of Latin America Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Rest of Latin America Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Rest of Latin America Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Rest of Latin America Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Latin America Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Rest of Latin America Bortezomib Market, by Types
-
Latin America Bortezomib Market, by Types
- Middle East & Africa
-
Middle East & Africa Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
-
Middle East & Africa Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
-
Middle East & Africa Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
-
Middle East & Africa Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
-
Middle East & Africa Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Middle East & Africa Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- GCC Countries
- GCC Countries Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- GCC Countries Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- GCC Countries Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- GCC Countries Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- GCC Countries Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- GCC Countries Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- GCC Countries Bortezomib Market, by Types
- South Africa
- South Africa Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- South Africa Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- South Africa Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- South Africa Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- South Africa Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South Africa Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- South Africa Bortezomib Market, by Types
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Bortezomib Market, by Types
- 1mg
- 3.5mg
- 5mg
- Others
- Rest of Middle East & Africa Bortezomib Market, by Applications
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Others
- Rest of Middle East & Africa Bortezomib Market, by Route of Administration
- Oral
- Intravenous
- Subcutaneous
- Others
- Rest of Middle East & Africa Bortezomib Market, by Dosage
- Tablet
- Injection
- Powder
- Others
- Rest of Middle East & Africa Bortezomib Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Middle East & Africa Bortezomib Market, by End-Users
- Clinic
- Hospital
- Others
- Rest of Middle East & Africa Bortezomib Market, by Types
-
Middle East & Africa Bortezomib Market, by Types
- North America
Vantage Market
Research | 29-Jan-2025
FAQ
Frequently Asked Question
What is the global demand for Bortezomib in terms of revenue?
-
The global Bortezomib valued at USD 25.1 Million in 2024 and is expected to reach USD 41.16 Million in 2035 growing at a CAGR of 4.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Dr. Reddy's Laboratories, TAPI Teva, Chem-Stone (Guangzhou), Gland Pharma, Pfizer, Scion Pharmaceuticals, Meitheal Pharmaceuticals, Vinkem Labs, Hikma Pharmaceuticals, Farmhispania Group, Shilpa Medicare, Hubei Honch Pharmaceutical, Novartis International AG, Teva Pharmaceuticals, Chengdu Aslee Biopharmaceuticals, NATCO Pharma, Qilu Pharmaceutical, Icrom, Coresyn, Bristol Myers Squibb..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.6% between 2025 and 2035.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Bortezomib include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Bortezomib in 2024.
